Global Active Pharmaceutical Ingredients Market Bwc19271

Home Healthcare And Pharmaceutical Global Active Pharmaceutical Ingredients Market Bwc19271

Active Pharmaceutical Ingredients (API) Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019–2029, Segmented By API (Synthetic API, Biological API); By Manufacturer (Captive Manufacturers, Merchant Manufacturers); By Type of Drug (Branded/Innovator Drugs, Generic Drugs); By Therapeutic Area (Cardiovascular System, Central Nervous System (CNS), Respiratory System, Oncology, Gastrointestinal System, Others); By Potency (Traditional API, HPAPI); Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa)

Published Date: July 2023
Report ID: BWC19271
Available Format: PDF
Page: 400

Report Overview

The growth of the Active Pharmaceutical Ingredients Market can be ascribed to the increasing demand for generic drugs, the rising prevalence of chronic diseases and the growing focus on research and development of new APIs

Global Active Pharmaceutical Ingredients (API) Market – Market Trends & Forecast Report 2029

The global active pharmaceutical ingredients (API) market was worth USD 232.4 Billion in 2022, and it is further projected to reach USD 324.67 Billion by 2029, at a CAGR of 5.69% during 2019–2029 (forecast period). The global active pharmaceutical ingredients (API) market is driven by the increasing prevalence of chronic diseases and the growing global population are driving the demand for pharmaceutical drugs, which in turn fuels the API market. Additionally, the rise in generic drug manufacturing and the need for cost-effective healthcare solutions are contributing to market growth. The outsourcing of API production to emerging economies, favorable government regulations, and advancements in technology are also propelling the market. Furthermore, the increasing focus on research and development activities, the expansion of pharmaceutical companies into new markets, and strategic collaborations and partnerships are key factors driving the global API market.

Active Pharmaceutical Ingredients (API) Market

Active Pharmaceutical Ingredients - Overview

Active Pharmaceutical Ingredients (APIs) are the essential components of pharmaceutical drugs that provide therapeutic effects. They are biologically active substances responsible for the desired physiological response in patients. APIs can be either chemically synthesized or derived from natural sources such as plants, animals, or microorganisms. API manufacturers play a crucial role in the pharmaceutical industry. They ensured the quality, safety, and efficacy of APIs through stringent manufacturing processes and adherence to regulatory guidelines. The market is characterized by intense competition, technological advancements, and increasing investments in research and development activities. Overall, the API market is a vital component of the pharmaceutical industry, supplying the necessary ingredients for the development and production of various drugs that improve global healthcare outcomes.

Global Active Pharmaceutical Ingredients (API) Market

Growth Drivers

Rising Prevalence of Chronic Diseases

Chronic diseases, such as cardiovascular diseases, diabetes, cancer, respiratory diseases, and neurological disorders, pose a significant healthcare burden globally. APIs are the key components used in the production of medications to treat and manage these chronic conditions. As the global population continues to grow and age, the incidence of chronic diseases is increasing. This demographic shift, coupled with changing lifestyles and risk factors, has led to a surge in the demand for effective pharmaceutical treatments. Consequently, the global API market is experiencing a substantial boost. For instance, cardiovascular diseases, including hypertension and coronary artery disease, are among the leading causes of death worldwide. According to the World Health Organization (WHO), chronic diseases account for 7 out of 10 deaths globally. In 2020, chronic diseases caused 41 million deaths or 75% of all deaths. Whereas cardiovascular diseases are the leading cause of death from chronic diseases, accounting for 17.9 million deaths in 2020 and cancer is the second leading cause of death from chronic diseases, accounting for 9.5 million deaths in 2020. APIs, such as antihypertensives, lipid-lowering agents, and antiplatelet drugs, are extensively utilized in the production of medications to manage these conditions. With the increasing prevalence of cardiovascular diseases, there is a growing need for APIs that can cater to the rising demand for cardiovascular medications. Similarly, the rising incidence of diabetes is driving the demand for APIs used in the production of antidiabetic drugs, such as insulin and oral hypoglycemic agents. Globally, diabetes is the fourth leading cause of death from chronic diseases, accounting for 3.2 million deaths in 2020. As diabetes becomes more prevalent worldwide, the API market experiences significant growth in response to the escalating demand for effective diabetes treatments.

Restraints

Stringent Regulatory Requirements

Stringent regulatory requirements can pose a significant restraint on the growth of global active pharmaceutical ingredients (API) market. Regulatory agencies around the world, such as the US Food and Drug Administration (US FDA) and the European Medicines Agency (EMA), enforce strict guidelines and regulations to ensure the safety, efficacy, and quality of APIs used in pharmaceutical products. These regulations often require extensive documentation, compliance with Good Manufacturing Practices (GMP), and rigorous testing and validation procedures. While these measures are crucial for patient safety and public health, they can increase the time and cost involved in API development and manufacturing. For example, in the United States, the Drug Master File (DMF) system requires API manufacturers to submit comprehensive information about their processes, quality control, and safety data. This can be a time-consuming and resource-intensive process. According to a report by the International Pharmaceutical Federation (FIP), the average cost of developing a new API is USD 100 million. This includes the cost of research and development, clinical trials, and regulatory approval. The cost of regulatory approval can be particularly high, as it can involve multiple rounds of testing and review. Compliance with regulations such as Current Good Manufacturing Practices (cGMP) also necessitates significant investments in infrastructure, equipment, and personnel training. Companies must maintain meticulous records and undergo regular inspections to ensure compliance, adding to the overall cost of API production. These stringent regulatory requirements can be particularly challenging for small and medium-sized API manufacturers, as they may lack the resources and expertise to navigate the complex regulatory landscape effectively. It can also create barriers to entry for new market players, limiting competition and innovation.

Impact of COVID–19 on Global Active Pharmaceutical Ingredients (API) Market

The global active pharmaceutical ingredients (API) market was significantly impacted by the COVID-19 pandemic. The outbreak led to increased demand for specific APIs used in the treatment of COVID-19 and related conditions. Companies like Mylan and Teva Pharmaceutical responded by ramping up production to meet the surge in demand. However, the pandemic also brought disruptions to global supply chains, hindering the availability of APIs. Aurobindo Pharma and Sun Pharmaceutical, among others, faced challenges in API manufacturing and distribution due to supply chain disruptions. Manufacturing operations were also affected, as companies had to navigate social distancing measures and workforce limitations. Dr. Reddy's Laboratories and Lupin Limited experienced manufacturing constraints during the pandemic. In April 2020, Dr. Reddy's Laboratories announced that it was suspending production at its API manufacturing facility in India due to the COVID-19 pandemic. The suspension of production led to a shortage of few APIs, which increased the prices of these ingredients. On the regulatory front, authorities implemented measures to fast-track the approval and production of COVID-19 drugs, collaborating with companies like Pfizer and Moderna in expediting the process. In July 2020, the US Food and Drug Administration (FDA) issued guidance on the approval of new APIs for COVID-19 treatments. The guidance was designed to expedite the approval process for new APIs that are needed to treat COVID-19. Moreover, the pandemic highlighted the importance of domestic API production for ensuring drug availability during crises. Lonza Group and Cipla, for example, focused on strengthening local API manufacturing capacities to reduce reliance on imports.

Global Active Pharmaceutical Ingredients (API) Market – By API

Based on API, the global active pharmaceutical ingredients (API) market is segmented into synthetic API and biological API. In the global active pharmaceutical ingredients (API) market, the synthetic APIs segment has been holding a larger market share primarily due to these APIs offering advantages in terms of manufacturing scalability, cost-effectiveness, and regulatory compliance. Synthetic APIs are chemically synthesized, allowing for greater control over the production process, reproducibility, and standardization. This enables manufacturers to produce large quantities of APIs efficiently, meeting the high demand for pharmaceutical drugs. Additionally, synthetic APIs often have a broader range of applications across various therapeutic areas. They can be formulated into a diverse range of drug products, catering to the treatment of different diseases and conditions. The versatility of synthetic APIs makes them attractive to pharmaceutical companies, enabling them to develop and produce a wide array of medications. Synthetic APIs also have a longer history of development and commercialization compared to biological APIs. The advancements in synthetic chemistry and process optimization have contributed to the establishment of a robust infrastructure for manufacturing synthetic APIs at a large scale.

Global Active Pharmaceutical Ingredients (API) Market – By Type of Drug

Based on the type of drugs, the global active pharmaceutical ingredients (API) market is segmented into branded/innovator drugs and generic drugs. The generic drugs segment holds a higher market share in the global active pharmaceutical ingredients (API) market and is expected to continue leading the market till 2029. The expiration of patents for branded drugs plays a crucial role. Once a patent expires, generic drug manufacturers can enter the market, offering equivalent versions of the drug at lower prices. This opens up opportunities for generic drug production, leading to increased competition and market growth. Moreover, generic drugs are highly sought after due to their cost-effectiveness. They provide the same therapeutic benefits as their branded counterparts but at significantly reduced prices. This affordability makes them accessible to a broader population, attracting patients, healthcare providers, and healthcare systems alike. The rising demand for cost-effective healthcare solutions further drives the market for generic drugs. Additionally, the approval process for generic drugs is streamlined, as they can leverage existing safety and efficacy data from the innovator drugs. This shorter and less expensive process allows generic manufacturers to bring their products to market quickly, ensuring a steady supply of affordable alternatives. The combination of patent expirations, cost-effectiveness, and accessibility has propelled the growth of the generic drug segment in the API market. The generic drugs segment continues to expand, meeting the rising demand for affordable treatment options and playing a significant role in improving healthcare outcomes worldwide.

Global Active Pharmaceutical Ingredients (API) Market - Regional Insights

In terms of regional analysis, the global active pharmaceutical ingredients (API) market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. During the period in analysis, North America is expected to continue to hold the largest market share in the global active pharmaceutical ingredients (API), as it has an established and advanced pharmaceutical industry, with major companies, research institutions, and academic centers. This infrastructure supports the development, manufacturing, and innovation of APIs. North America also has a high level of healthcare expenditure, indicating a strong demand for pharmaceutical drugs, which in turn drives the API market. The region's focus on advanced healthcare infrastructure and quality standards further contributes to this demand. North America emphasizes R&D in the pharmaceutical sector, resulting in increased API requirements for drug discovery and development. The favorable regulatory environment, with stringent quality and safety regulations, supports the production of high-quality APIs. While North America currently holds the largest market share, it is essential to stay updated with the latest market reports for the most accurate and current information on the regional dynamics of the API market.

Competitive Landscape

The global active pharmaceutical ingredients (API) market is characterized by many regional and global vendors. The key players operating in the global active pharmaceutical ingredients (API) market include Teva Pharmaceutical Industries Ltd, Pfizer Inc., Novartis International AG, Mylan N.V., Aurobindo Pharma Ltd, Sun Pharmaceutical Industries Ltd, Boehringer Ingelheim GmbH, Dr. Reddy's Laboratories Ltd, Merck & Co, Inc., Lonza Group Ltd, Bristol–Myers Squibb, GlaxoSmithKline plc, AbbVie Inc., Lupin Limited, and Cipla Ltd. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Recent Developments

In April 2023 - Dr. Reddy's Laboratories inaugurated a new API facility in India to produce APIs for a variety of drugs, including cancer drugs, antibiotics, and cardiovascular drugs.
In March 2023 - BASF announced the expansion of its API manufacturing capacity in China. The expansion is expected to increase BASF's API production capacity by 50%.
In February 2023 - Pfizer acquired Arena Pharmaceuticals, a biopharmaceutical company that develops APIs for a variety of drugs, including migraine drugs and diabetes drugs.
In January 2023 - Sun Pharmaceutical Industries launched a new API facility in the United States to produce APIs for a variety of drugs, including cancer drugs, antibiotics, and cardiovascular drugs.

Scope of the Report

Attribute	Details
Years Considered	Historical Data – 2019–2022
	Base Year – 2022
	Estimated Year – 2023
	Forecast – 2023–2029
Facts Covered	Revenue in USD Billion
Market Coverage	North America (US, Canada), Europe (Germany, UK, France, Italy, Spain, Belgium, Russia, The Netherlands, Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia & New Zealand, Indonesia, Malaysia, Singapore, Vietnam, Rest of Asia Pacific), Latin America (Brazil, Mexico, Argentina, Peru, Rest of Latin America), Middle East & Africa (Saudi Arabia, UAE, Qatar, Kuwait, South Africa, Nigeria, Algeria, Rest of Middle East and Africa)
Product/Service Segmentation	API, Manufacturer, Type of Drug, Therapeutic Area, Potency, Region
Key Players	Teva Pharmaceutical Industries Ltd, Pfizer Inc., Novartis International AG, Mylan N.V., Aurobindo Pharma Ltd, Sun Pharmaceutical Industries Ltd, Boehringer Ingelheim GmbH, Dr. Reddy's Laboratories Ltd, Merck & Co. Inc., Lonza Group Ltd, Bristol–Myers Squibb, GlaxoSmithKline plc, AbbVie Inc., Lupin Limited, Cipla Ltd

By API

Synthetic API
Biological API

By Manufacturer

Captive Manufacturers
Merchant Manufacturers

By Type of Drug

Branded/Innovator Drugs
Generic Drugs

By Therapeutic Area

Cardiovascular System
Central Nervous System (CNS)
Respiratory System
Oncology
Gastrointestinal System
Others

By Potency

Traditional API
HPAPI

By Region

North America
Europe
Asia Pacific
Latin America
Middle East and Africa

Research Framework
1. Research Objective
2. Product Overview
3. Market Segmentation
Executive Summary
Global Active Pharmaceutical Ingredients (API) Market Insights
1. Industry Value Chain Analysis
2. DROC Analysis
  1. Growth Drivers
    1. Increasing demand for generic drugs
    2. Rising prevalence of chronic diseases
    3. Growing focus on research and development of new APIs
  2. Restrains
    1. Stringent regulatory requirements
    2. Price volatility
  3. Opportunities
    1. Growing demand from emerging markets
    2. Development of new technologies
  4. Challenges
    1. Regulatory challenges
    2. Competition from generics
3. Technology Advancements/Recent Developments
4. Regulatory Framework
5. Porter’s Five Forces Analysis
  1. Bargaining Power of Suppliers
  2. Bargaining Power of Buyers
  3. Threat of New Entrants
  4. Threat of Substitutes
  5. Intensity of Rivalry
Global Active Pharmaceutical Ingredients (API) Market Overview
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share and Forecast
  1. By API
    1. Synthetic API
    2. Biological API
  2. By Manufacturer
    1. Captive Manufacturers
    2. Merchant Manufacturers
  3. By Type of Drug
    1. Branded/Innovator Drugs
    2. Generic Drugs
  4. By Therapeutic Area
    1. Cardiovascular System
    2. Central Nervous System (CNS)
    3. Respiratory System
    4. Oncology
    5. Gastrointestinal System
    6. Others
  5. By Potency
    1. Traditional API
    2. HPAPI
  6. By Region
    1. North America
    2. Europe
    3. Asia Pacific (APAC)
    4. Latin America (LATAM)
    5. Middle East and Africa (MEA)
North America Active Pharmaceutical Ingredients (API) Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By API
  2. By Manufacturer
  3. By Type of Drug
  4. By Therapeutic Area
  5. By Potency
  6. By Country
    1. United States
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    2. Canada
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
Europe Active Pharmaceutical Ingredients (API) Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By API
  2. By Manufacturer
  3. By Type of Drug
  4. By Therapeutic Area
  5. By Potency
  6. By Country
    1. Germany
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    2. United Kingdom
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    3. Italy
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    4. France
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    5. Spain
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    6. Belgium
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    7. Russia
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    8. The Netherlands
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    9. Rest of Europe
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
Asia-Pacific Active Pharmaceutical Ingredients (API) Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By API
  2. By Manufacturer
  3. By Type of Drug
  4. By Therapeutic Area
  5. By Potency
  6. By Country
    1. China
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    2. India
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    3. Japan
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    4. South Korea
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    5. Australia & New Zealand
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    6. Indonesia
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    7. Malaysia
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    8. Singapore
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    9. Vietnam
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    10. Rest of APAC
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
Latin America Active Pharmaceutical Ingredients (API) Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. 1. By API
    2. By Manufacturer
    3. By Type of Drug
    4. By Therapeutic Area
    5. By Potency
  2. By Country
    1. Brazil
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    2. Mexico
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    3. Argentina
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    4. Peru
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    5. Rest of LATAM
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
Middle East & Africa Active Pharmaceutical Ingredients (API) Market
1. Market Size & Forecast, 2019–2029
  1. By Value (USD Million)
2. Market Share & Forecast
  1. By API
  2. By Manufacturer
  3. By Type of Drug
  4. By Therapeutic Area
  5. By Potency
  6. By Country
    1. Saudi Arabia
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    2. UAE
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    3. Qatar
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    4. Kuwait
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    5. South Africa
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    6. Nigeria
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    7. Algeria
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
    8. Rest of MEA
      1. By API
      2. By Manufacturer
      3. By Type of Drug
      4. By Therapeutic Area
      5. By Potency
Competitive Landscape
1. List of Key Players and Their Offerings
2. Global Active Pharmaceutical Ingredients (API) Market Share Analysis, 2022
3. Competitive Benchmarking, By Operating Parameters
4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)
Impact of Covid–19 on India Worm Gear Reducers Market
Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)
1. Teva Pharmaceutical Industries Ltd
2. Pfizer Inc.
3. Novartis International AG
4. Mylan N.V.
5. Aurobindo Pharma Ltd
6. Sun Pharmaceutical Industries Ltd
7. Boehringer Ingelheim GmbH
8. Dr. Reddy's Laboratories Ltd
9. Merck & Co., Inc.
10. Lonza Group Ltd
11. Bristol–Myers Squibb
12. GlaxoSmithKline plc
13. AbbVie Inc.
14. Lupin Limited
15. Cipla Ltd
16. Other Prominent Players
Key Strategic Recommendations
Research Methodology
1. Qualitative Research
  1. Primary & Secondary Research
2. Quantitative Research
3. Market Breakdown & Data Triangulation
  1. Secondary Research
  2. Primary Research
4. Breakdown of Primary Research Respondents, By Region
5. Assumptions & Limitations

*Financial information of case of non–listed companies can be provided as per availability.

**The segmentation and the companies are subject to modifications based on in–depth secondary research for the final deliverable

Figures

Figure 1 Global Active Pharmaceutical Ingredients (API) Market Segmentation

Figure 2 Global Active Pharmaceutical Ingredients (API) Market - Market Value Chain Analysis

Figure 3 Company Market Share Analysis, 2022

Figure 4 Global Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 5 Global Active Pharmaceutical Ingredients (API) Market - Market Share, By API, By Value, 2019−2029

Figure 6 Global Active Pharmaceutical Ingredients (API) Market - Market Share, By Manufacturer, By Value, 2019−2029

Figure 7 Global Active Pharmaceutical Ingredients (API) Market - Market Share, By Type of Drug, By Value, 2019−2029

Figure 8 Global Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 9 Global Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 11 Global Active Pharmaceutical Ingredients (API) Market, Market Share, By Region, By Value, 2019−2029

Figure 12 North America Active Pharmaceutical Ingredients (API) Market, Market Size, By Value (USD Billion), 2019−2029

Figure 13 North America Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 14 North America Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 15 North America Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 16 North America Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 17 North America Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 19 North America Active Pharmaceutical Ingredients (API) Market, Market Share, By Country, By Value, 2019−2029

Figure 20 United States Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 21 United States Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 22 United States Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 23 United States Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 24 United States Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 25 United States Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 26 Canada Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 27 Canada Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 28 Canada Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 29 Canada Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 30 Canada Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 31 Canada Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 32 Europe Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 33 Europe Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 34 Europe Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 35 Europe Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 36 Europe Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 37 Europe Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 38 Europe Active Pharmaceutical Ingredients (API) Market, Market Share, By Country, By Value, 2019−2029

Figure 39 Germany Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 40 Germany Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 41 Germany Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 42 Germany Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 43 Germany Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 44 Germany Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 45 United Kingdom Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 46 United Kingdom Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 47 United Kingdom Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 48 United Kingdom Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 49 United Kingdom Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 50 United Kingdom Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 51 Italy Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 52 Italy Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 53 Italy Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 54 Italy Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 55 Italy Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 56 Italy Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 57 France Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 58 France Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 59 France Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 60 France Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 61 France Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 62 France Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 63 Spain Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 64 Spain Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 65 Spain Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 66 Spain Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 67 Spain Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 68 Spain Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 69 The Netherlands Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 70 The Netherlands Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 71 The Netherlands Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 72 The Netherlands Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 73 The Netherlands Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 74 The Netherlands Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 75 Belgium Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 76 Belgium Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 77 Belgium Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 78 Belgium Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 79 Belgium Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 80 Belgium Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 81 Rest of Europe Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 82 Rest of Europe Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 83 Rest of Europe Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 84 Rest of Europe Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 85 Rest of Europe Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 86 Rest of Europe Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 87 Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 88 Asia-Pacific Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 89 Asia-Pacific Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 90 Asia-Pacific Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 91 Asia-Pacific Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 92 Asia-Pacific Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 93 Asia-Pacific Active Pharmaceutical Ingredients (API) Market, Market Share, By Country, By Value, 2019−2029

Figure 94 China Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 95 China Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 96 China Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 97 China Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 98 China Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 99 China Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 100 India Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 101 India Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 102 India Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 103 India Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 104 India Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 105 India Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 106 Japan Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 107 Japan Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 108 Japan Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 109 Japan Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 110 Japan Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 111 Japan Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 112 South Korea Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 113 South Korea Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 114 South Korea Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 115 South Korea Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 116 South Korea Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 117 South Korea Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 118 Australia & New Zealand Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 119 Australia & New Zealand Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 120 Australia & New Zealand Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 121 Australia & New Zealand Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 122 Australia & New Zealand Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 123 Australia & New Zealand Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 124 Indonesia Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 125 Indonesia Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 126 Indonesia Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 127 Indonesia Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 128 Indonesia Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 129 Indonesia Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 130 Malaysia Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 131 Malaysia Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 132 Malaysia Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 133 Malaysia Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 134 Malaysia Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 135 Malaysia Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 136 Singapore Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 137 Singapore Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 138 Singapore Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 139 Singapore Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 140 Singapore Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 141 Singapore Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 142 Philippines Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 143 Philippines Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 144 Philippines Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 145 Philippines Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 146 Philippines Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 147 Philippines Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 148 Vietnam Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 149 Vietnam Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 150 Vietnam Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 151 Vietnam Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 152 Vietnam Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 153 Vietnam Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 154 Rest of APAC Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 155 Rest of APAC Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 156 Rest of APAC Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 157 Rest of APAC Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 158 Rest of APAC Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 159 Rest of APAC Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 160 Latin America Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 161 Latin America Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 162 Latin America Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 163 Latin America Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 164 Latin America Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 165 Latin America Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 166 Latin America Active Pharmaceutical Ingredients (API) Market, Market Share, By Country, By Value, 2019−2029

Figure 167 Brazil Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 168 Brazil Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 169 Brazil Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 170 Brazil Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 171 Brazil Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 172 Brazil Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 173 Mexico Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 174 Mexico Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 175 Mexico Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 176 Mexico Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 177 Mexico Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 178 Mexico Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 179 Argentina Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 180 Argentina Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 181 Argentina Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 182 Argentina Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 183 Argentina Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 184 Argentina Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 185 Peru Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 186 Peru Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 187 Peru Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 188 Peru Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 189 Peru Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 190 Peru Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 191 Colombia Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 192 Colombia Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 193 Colombia Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 194 Colombia Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 195 Colombia Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 196 Colombia Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 197 Rest of LATAM Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 198 Rest of LATAM Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 199 Rest of LATAM Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 200 Rest of LATAM Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 201 Rest of LATAM Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 202 Rest of LATAM Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 203 Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 204 Middle East & Africa Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 205 Middle East & Africa Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 206 Middle East & Africa Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 207 Middle East & Africa Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 208 Middle East & Africa Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 209 Middle East & Africa Active Pharmaceutical Ingredients (API) Market, Market Share, By Country, By Value, 2019−2029

Figure 210 Saudi Arabia Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 211 Saudi Arabia Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 212 Saudi Arabia Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 213 Saudi Arabia Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 214 Saudi Arabia Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 215 Saudi Arabia Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 216 UAE Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 217 UAE Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 218 UAE Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 219 UAE Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 220 UAE Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 221 UAE Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 222 Qatar Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 223 Qatar Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 224 Qatar Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 225 Qatar Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 226 Qatar Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 227 Qatar Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 228 Kuwait Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 229 Kuwait Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 230 Kuwait Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 231 Kuwait Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 232 Kuwait Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 233 Kuwait Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 234 Iran Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 235 Iran Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 236 Iran Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 237 Iran Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 238 Iran Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 239 Iran Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 240 South Africa Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 241 South Africa Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 242 South Africa Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 243 South Africa Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 244 South Africa Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 245 South Africa Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 246 Nigeria Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 247 Nigeria Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 248 Nigeria Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 249 Nigeria Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 250 Nigeria Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 251 Nigeria Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 252 Kenya Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 253 Kenya Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 254 Kenya Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 255 Kenya Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 256 Kenya Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 257 Kenya Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 258 Egypt Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 259 Egypt Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 260 Egypt Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 261 Egypt Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 262 Egypt Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 263 Egypt Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 264 Morocco Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 265 Morocco Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 266 Morocco Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 267 Morocco Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 268 Morocco Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 269 Morocco Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 270 Algeria Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 271 Algeria Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 272 Algeria Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 273 Algeria Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 274 Algeria Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 275 Algeria Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

Figure 276 Rest of MEA Active Pharmaceutical Ingredients (API) Market Size, By Value (USD Billion), 2019−2029

Figure 277 Rest of MEA Active Pharmaceutical Ingredients (API) Market, Market Share, By API, By Value, 2019−2029

Figure 278 Rest of MEA Active Pharmaceutical Ingredients (API) Market, Market Share, By Manufacturer, By Value, 2019−2029

Figure 279 Rest of MEA Active Pharmaceutical Ingredients (API) Market, Market Share, By Type of Drug, By Value, 2019−2029

Figure 280 Rest of MEA Active Pharmaceutical Ingredients (API) Market, Market Share, By Therapeutic Area, By Value, 2019−2029

Figure 281 Rest of MEA Active Pharmaceutical Ingredients (API) Market, Market Share, By End User, By Value, 2019−2029

List of Tables

Table 1 Global Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 2 Global Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 3 Global Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 4 Global Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 5 Global Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 6 Global Active Pharmaceutical Ingredients (API) Market Size, By Region, By Value, 2019−2029

Table 7 North America Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 8 North America Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 9 North America Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 11 North America Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 12 North America

Table 13 North America Active Pharmaceutical Ingredients (API) Market Size, By Country, By Value, 2019−2029

Table 14 United States Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 15 United States Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 16 United States Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 17 United States Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 19 Canada Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 20 Canada Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 21 Canada Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 22 Canada Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 23 Canada Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 24 Europe Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 25 Europe Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 26 Europe Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 27 Europe Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 28 Europe Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 29 Europe Active Pharmaceutical Ingredients (API) Market Size, By Country, By Value, 2019−2029

Table 30 Germany Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 31 Germany Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 32 Germany Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 33 Germany Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 34 Germany Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 35 United Kingdom Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 36 United Kingdom Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 37 United Kingdom Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 38 United Kingdom Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 39 United Kingdom Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 40 Italy Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 41 Italy Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 42 Italy Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 43 Italy Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 44 Italy Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 45 France Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 46 France Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 47 France Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 48 France Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 49 France Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 50 Spain Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 51 Spain Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 52 Spain Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 53 Spain Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 54 Spain Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 55 The Netherlands Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 56 The Netherlands Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 57 The Netherlands Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 58 The Netherlands Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 59 The Netherlands Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 60 Belgium Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 61 Belgium Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 62 Belgium Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 63 Belgium Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 64 Belgium Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 65 Rest of Europe Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 66 Rest of Europe Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 67 Rest of Europe Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 68 Rest of Europe Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 69 Rest of Europe Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 70 Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 71 Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 72 Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 73 Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 74 Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 75 Asia-Pacific Active Pharmaceutical Ingredients (API) Market Size, By Country, By Value, 2019−2029

Table 76 China Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 77 China Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 78 China Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 79 China Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 80 China Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 81 India Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 82 India Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 83 India Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 84 India Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 85 India Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 86 Japan Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 87 Japan Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 88 Japan Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 89 Japan Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 90 Japan Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 91 South Korea Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 92 South Korea Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 93 South Korea Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 94 South Korea Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 95 South Korea Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 96 Australia & New Zealand Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 97 Australia & New Zealand Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 98 Australia & New Zealand Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 99 Australia & New Zealand Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 100 Australia & New Zealand Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 101 Indonesia Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 102 Indonesia Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 103 Indonesia Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 104 Indonesia Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 105 Indonesia Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 106 Malaysia Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 107 Malaysia Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 108 Malaysia Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 109 Malaysia Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 110 Malaysia Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 111 Singapore Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 112 Singapore Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 113 Singapore Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 114 Singapore Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 115 Singapore Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 116 Philippines Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 117 Philippines Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 118 Philippines Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 119 Philippines Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 120 Philippines Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 121 Vietnam Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 122 Vietnam Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 123 Vietnam Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 124 Vietnam Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 125 Vietnam Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 126 Rest of APAC Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 127 Rest of APAC Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 128 Rest of APAC Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 129 Rest of APAC Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 130 Rest of APAC Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 131 Latin America Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 132 Latin America Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 133 Latin America Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 134 Latin America Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 135 Latin America Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 136 Latin America Active Pharmaceutical Ingredients (API) Market Size, By Country, By Value, 2019−2029

Table 137 Brazil Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 138 Brazil Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 139 Brazil Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 140 Brazil Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 141 Brazil Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 142 Mexico Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 143 Mexico Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 144 Mexico Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 145 Mexico Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 146 Mexico Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2030

Table 147 Argentina Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 148 Argentina Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 149 Argentina Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 150 Argentina Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 151 Argentina Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 152 Peru Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 153 Peru Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 154 Peru Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 155 Peru Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 156 Peru Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 157 Colombia Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 158 Colombia Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 159 Colombia Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 160 Colombia Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 161 Colombia Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 162 Rest of LATAM Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 163 Rest of LATAM Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 164 Rest of LATAM Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 165 Rest of LATAM Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 166 Rest of LATAM Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 167 Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 168 Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 169 Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 170 Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 171 Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 172 Middle East & Africa Active Pharmaceutical Ingredients (API) Market Size, By Country, By Value, 2019−2029

Table 173 Saudi Arabia Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 174 Saudi Arabia Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 175 Saudi Arabia Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 176 Saudi Arabia Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 177 Saudi Arabia Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 178 UAE Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 179 UAE Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 180 UAE Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 181 UAE Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 182 UAE Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 183 Qatar Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 184 Qatar Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 185 Qatar Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 186 Qatar Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 187 Qatar Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 188 Kuwait Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 189 Kuwait Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 190 Kuwait Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 191 Kuwait Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 192 Kuwait Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 193 Iran Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 194 Iran Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 195 Iran Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 196 Iran Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 197 Iran Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 198 South Africa Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 199 South Africa Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 200 South Africa Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 201 South Africa Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 202 South Africa Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 203 Nigeria Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 204 Nigeria Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 205 Nigeria Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 206 Nigeria Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 207 Nigeria Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 208 Kenya Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 209 Kenya Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 210 Kenya Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 211 Kenya Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 212 Kenya Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 213 Egypt Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 214 Egypt Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 215 Egypt Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 216 Egypt Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 217 Egypt Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 218 Morocco Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 219 Morocco Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 220 Morocco Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 221 Morocco Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 222 Morocco Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 223 Algeria Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 224 Algeria Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 225 Algeria Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 226 Algeria Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 227 Algeria Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 228 Rest of MEA Active Pharmaceutical Ingredients (API) Market Size, By API, By Value, 2019−2029

Table 229 Rest of MEA Active Pharmaceutical Ingredients (API) Market Size, By Manufacturer, By Value, 2019−2029

Table 230 Rest of MEA Active Pharmaceutical Ingredients (API) Market Size, By Type of Drug, By Value, 2019−2029

Table 231 Rest of MEA Active Pharmaceutical Ingredients (API) Market Size, By Therapeutic Area, By Value, 2019−2029

Table 232 Rest of MEA Active Pharmaceutical Ingredients (API) Market Size, By End User, By Value, 2019−2029

Table 233 Teva Pharmaceutical Industries Ltd Company Overview

Table 234 Teva Pharmaceutical Industries Ltd Financial Overview

Table 235 Pfizer Inc. Company Overview

Table 236 Pfizer Inc. Financial Overview

Table 237 Novartis International AG Company Overview

Table 238 Novartis International AG Financial Overview

Table 239 Mylan N.V. Company Overview

Table 240 Mylan N.V. Financial Overview

Table 241 Aurobindo Pharma Ltd Company Overview

Table 242 Aurobindo Pharma Ltd Financial Overview

Table 243 Sun Pharmaceutical Industries Ltd Company Overview

Table 244 Sun Pharmaceutical Industries Ltd Financial Overview

Table 245 Boehringer Ingelheim GmbH Company Overview

Table 246 Boehringer Ingelheim GmbH Financial Overview

Table 247 Dr. Reddy's Laboratories Ltd Company Overview

Table 248 Dr. Reddy's Laboratories Ltd Financial Overview

Table 249 Merck & Co., Inc. Company Overview

Table 250 Merck & Co., Inc. Financial Overview

Table 251 Lonza Group Ltd Company Overview

Table 252 Lonza Group Ltd Financial Overview

Table 253 Bristol-Myers Squibb Company Overview

Table 254 Bristol-Myers Squibb Financial Overview

Table 255 Cipla Ltd Company Overview

Table 256 Cipla Ltd Financial Overview

Table 257 Other Prominent Players Company Overview

Table 258 Other Prominent Players Financial Overview

Market Segmentation

No data available

To request a free sample copy of this report, please complete the form below.

We value your investment and offer free customization with every report to fulfil your exact research needs.

Yes, I have read the privacy policy

This website is secure and your personal details are safe.

Frequently Asked Questions (FAQs):

1. Which region is the leading region in Global Active Pharmaceutical Ingredients (API) Market?

Ans: North America holds the highest market share in the Global Active Pharmaceutical Ingredients (API) Market.

2. What is the current size of the Global Active Pharmaceutical Ingredients (API) Market?

Ans: Global Active Pharmaceutical Ingredients (API) Market size was estimated at USD 232.4 Billion in 2022.

3. What are the major factors driving the growth of the Global Active Pharmaceutical Ingredients (API) Market?

Ans: The growth of Global Active Pharmaceutical Ingredients (API) Market can be ascribed to the increasing demand for generic drugs, the rising prevalence of chronic diseases, and the growing focus on R&D of new APIs.

4. Name the key players in the Global Active Pharmaceutical Ingredients (API) Market.

Ans: The key players operating in the Global Active Pharmaceutical Ingredients (API) Market include Teva Pharmaceutical Industries Ltd, Pfizer Inc., Novartis International AG, Mylan N.V., Aurobindo Pharma Ltd, Sun Pharmaceutical Industries Ltd, Boehringer Ingelheim GmbH, Dr. Reddy's Laboratories Ltd, Merck & Co. Inc., Lonza Group Ltd, Bristol–Myers Squibb, GlaxoSmithKline plc, AbbVie Inc., Lupin Limited, and Cipla Ltd.

5. Which product segment is expected to grow at a higher CAGR in Global Active Pharmaceutical Ingredients (API) Market?

Ans: The generic drugs segment is expected to grow at higher CAGR in the Global Active Pharmaceutical Ingredients (API) Market by product at a higher rate during the forecast period.

PLACE AN ORDER

SINGLE USER LICENSE
$ 4850
GROUP LICENSE
$ 5750
ENTERPRISE LICENSE
$ 8150
EXCEL DATA PACK
$ 3250

Request for Sample

RELATED REPORTS

WHY CHOOSE US

24/7 Research Support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Custom Research Service

Ask the Analyst to customize an exclusive study to serve your research needs
Quality & Accuracy

Ask the Analyst to customize an exclusive study to serve your research needs
Data Visualization

As the business world is changing dynamically every day. We need to stay pin point in relation to data management and optimum data utilization
Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.